Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Hemal Gada

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Philip Green

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Isaac George

September 16, 2014

Presentation TCT 2014

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Presenter: Ran Kornowski

September 16, 2014

News Conference News TCT 2013

Two Trials to Assess TAVR in Moderate-Risk Patients

October 30, 2013

Presentation TCT 2012

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

Presenter: John Webb

October 22, 2012

Advertisement

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

TCT 2019 Day Two: Transcatheter Valves, New and Old

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Case Presentation

Case Presentation

Case Presentation

Case Presentation

Characterization of the Impact of Transcatheter Aortic Valve Implantation on Mitral Regurgitation Regression in High Risk Patients With Aortic Stenosis

Two Trials to Assess TAVR in Moderate-Risk Patients

Moderate or Severe Mitral Regurgitation and Aortic Stenosis: Surgery or TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content